Altered amyloid protein processing in platelets of patients with Alzheimer disease

Archives of Neurology

Volumn 54, Issue 2, 1997, Pages 139-144

  Rosenberg, Roger N ^a   Baskin, Fred ^a   Fosmire, Jennifer A ^a   Risser, Rick ^a   Adams, Perrie ^b   Svetlik, Doris ^b   Honig, Lawrence S ^a   Cullum, C Munro ^a,b   Weiner, Myron F ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0031047350     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550140019007     Document Type: Article

References (30)

1. Rosenberg RN. A causal role for amyloid in Alzhelmer's disease: the end of the beginning. Neurology, 1993;43:851-856.
2. Selkoe DJ, Alzhelmer's disease: a central role for amyloid. J Neuropathol Exp Neurol. 1994;53:438-447.
3. Bush AI, Martins RN, Rumble B, et al. The amyloid precursor protein of Alzhelmer's disease is released by human platelets. J Biol Chem. 1990;265:15977-15983.
4. Schlossmacher MG, Ostaszewski BL, Hecker LI, et al. Detection of distinct isoform patterns of the beta-amyloid precursor protein in human platelets and lymphocytes, Neurobiol Aging. 1992;13:421-434.
5. Cole GM, Galasko D, Shapiro IP, Saitoh T. Stimulated platelets release amyloid b-protein precursor. Biochem Biophys Res Commun. 1990;170:288-295.
6. Gardella JE, Ghiso J, Gorgone GA, et al. Intact Alzhelmer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA. Biochem Biophys Res Commun. 1990;173:1292-1298.
7. Li QX, Berndt MC, Bush AI, et al. Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet. Blood. 1994;84:133-142.
8. Chen M, Inestrosa NC, Ross GS, Fernandez HL. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Commun. 1995;213:96-103.
9. Oltersdorf T, Fritz LC, Schenk DB, et al. The secreted form of the Alzhelmer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature. 1989;341:144-147.
10. Fukatsu R, Tsuzuki K, Takamanu Y, et al. Is APP in cultured cells and platelets processed in multiple pathways? Soc Neurosci. 1996;22:190. Abstract.
11. Gattaz WF, Levy R, Cairns NJ, et al. Alteration of the metabolism of membrane phospholipids in Alzheimer's disease. Fortschr Neurol Psychiatr. 1996;64:8-12.
12. Matsushima H, Shimohama S, Fujimoto S, et al. Reduction of platelet phospholipase C activity in patients with Alzhelmer disease. Alzheimer Dis Assoc Disord, 1995;9:213-217.
13. Matsushima H, Shimohama S, Tanaka S, et al. Platelet protein kinase C levels in Alzhelmer' disease. Neurobiol Aging. 1994;15:671-674.
14. Davies TA, Fine RE, Johnson RJ, et al. Non-age related differences in thrombin responses by platelets from male patients with advanced Alzheimer's disease. Biochem Biophys Res Commun, 1993;194:537-543.
15. Davies TA, Long HJ, Rathbun WH, et al. Platelets from patients with Alzheimer's disease or other dementias exhibit disease-specific and apolipoprotein E correlatable defects. Amyloid Int J Exp Clin Invest 1996;3:13-19.
16. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and Increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA, 1993;90:1977-1981.
17. Saunders AM, Hulette C, Welsh-Bohmer KA, et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996;348:90-93.
18. Hixson JE, Vernier DT. Restriction Isotyping of human APOE by gene amplification and cleavage with Hhal. J Lipid Res. 1990;31:545-548.
19. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group. Neurology. 1984;34:939-944.
20. Weiner M, Bruhn M, Svetlik D, et al. Experiences with depression in a dementia clinic. J Clin Psychol. 1991;52:234-238.
21. Patterson PM, Cytokines in Alzheimer's disease and multiple sclerosis. Curr Opin Neurobiol. 1995;5:642-646.
22. Huberman M, Shalit F, Roth-Deri I, et al. Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease state. J Neuroimmunol. 1994;52:147-152.
23. Kowalska MA, Badellino K, Beta-amyloid protein induces platelet aggregation and supports platelet adhesion. Biochem Biophys Res Commun. 1994;205:1829-1835.
24. Bush AI, Whyte S, Thomas LD, et al. An abnormality of plasma amyloid protein precursor in Alzheimer's disease. Ann Neurol, 1992;32:57-65.
25. LaDu MJ, Falduto MT, Manelli AM, et al. Isoform-speciflc binding of apolipoprotein E to β-amyloid. J Biol Chem. 1994;269:23403-23406.
26. Kounnas MZ, Moir RD, Rebeck GW, et al. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell. 1995;82:331-340.
27. Zubenko GS, Wusylko M, Cohen B, et al. Family study of platelet membrane fluidity in Alzheimer's disease. Science. 1987;238:539-542.
28. Vigo-Pelfrey C, Seubert P, Barbour R, et al. Elevation of microtubule-associated protein tan in the cerebrospinal fluid of Alzheimer's patients. Neurology. 1995;45:788-793.
29. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 1995;38:643-648.
30. DiLuca M, Pastorino L, Cattabeni F, et al. Abnormal pattern of platelet APP Isoforms in Alzheimer disease and Down Syndrome. Arch Neurol. 1996;53:1162-1166.